The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…
BMI View: It is vital that companies that are looking to sell non-communicable disease therapeutics work
alongside the public sector and focus on physician education and patient awareness in a market that has
traditionally focussed on infectious diseases such as malaria, tuberculosis and HIV. Besides challenges
related to diagnosis, care and treatment, there is a lack of understanding and knowledge about diseases
such as diabetes and cardiovascular disease among healthcare professionals and the general population,
and a perception that such diseases are not as critical as other diseases affecting the country.
Headline Expenditure Projections
? Pharmaceuticals: KES73.34bn (USD750mn) in 2015 to KES84.04bn (USD830mn) in 2016; 14.6%
growth in local currency terms and 10.8% in US dollar terms.
? Healthcare: KES341.18bn (USD3.47bn) in 2015 to KES377.30 (USD3.71bn) in 2016; 10.6% growth in
local currency terms and 7.0% in US dollar terms.